Beijing BIOOCUS Biotech Ltd. is proud to introduce our latest innovation in the fight against lung cancer - the LungCure™ diagnostic test. With China having the highest incidence of lung cancer in the world, early detection is crucial for better patient outcomes, LungCure™ is a non-invasive, highly sensitive molecular diagnostic test that uses advanced technology to detect specific genetic mutations associated with lung cancer. This test provides clinicians with valuable information to guide treatment decisions and monitor disease progression, Our team of dedicated scientists and researchers have worked tirelessly to develop a test that is not only accurate and reliable, but also affordable and accessible to a wide range of patients, With LungCure™, we aim to empower healthcare providers and patients with the information they need to make informed decisions about their lung cancer treatment. We at Beijing BIOOCUS Biotech Ltd. are committed to improving the lives of those affected by lung cancer, and LungCure™ is a significant step forward in achieving that goal
Please feel free to give your inquiry in the form below We will reply you in 24 hours